Literature DB >> 16464751

The influence of antidotal treatment of low-level tabun exposure on cognitive functions in rats using a water maze.

J Kassa1, G Kunesova.   

Abstract

In this study, the influence of antidotal treatment of tabun poisoning on cognitive function, in the case of low-level tabun exposure, was studied. The impairment of cognitive function was evaluated by the measurement of spatial learning and memory in rats poisoned with a sublethal dose of tabun and treated with atropine alone or in combination with newly developed oximes {K027 [1-(4-hydroxyiminomethyl- pyridinium)-3-(4-carbamoylpyridinium) propane dibromide] and K048 [1-(4-hydroxyimino- methylpyridinium)-3-(4-carbamoylpyridinium) butane dibromide]} or currently available oxime (trimedoxime), using the Morris water maze. While atropine alone caused an impairment of studied cognitive functions, the addition of an oxime to atropine contributes to the improvement of cognitive performance of treated tabun-poisoned rats regardless of the type of oxime. The differences in the ameliorative effects of oximes on atropine-induced mnemonic deficits were not significant. Therefore, each low-level nerve agent exposure should be treated by complex antidotal treatment consisting of anticholinergic drug and oxime.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16464751     DOI: 10.1007/BF03033306

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  33 in total

Review 1.  Neurotransmitter systems involved in learning and memory in the rat: a meta-analysis based on studies of four behavioral tasks.

Authors:  Trond Myhrer
Journal:  Brain Res Brain Res Rev       Date:  2003-03

2.  Synthesis of a new reactivator of tabun-inhibited acetylcholinesterase.

Authors:  Kamil Kuca; Jirí Bielavský; Jirí Cabal; Jirí Kassa
Journal:  Bioorg Med Chem Lett       Date:  2003-10-20       Impact factor: 2.823

Review 3.  Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment.

Authors:  Jirí Bajgar
Journal:  Adv Clin Chem       Date:  2004       Impact factor: 5.394

Review 4.  Central cholinergic nervous system and cholinergic agents.

Authors:  J Patocka
Journal:  Acta Medica (Hradec Kralove)       Date:  1998

Review 5.  Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents.

Authors:  J Kassa
Journal:  J Toxicol Clin Toxicol       Date:  2002

6.  Efficacy of biperiden and atropine as anticonvulsant treatment for organophosphorus nerve agent intoxication.

Authors:  T M Shih; J H McDonough
Journal:  Arch Toxicol       Date:  2000-05       Impact factor: 5.153

7.  Spatial memory impairment and central muscarinic receptor loss following prolonged treatment with organophosphates.

Authors:  B E McDonald; L G Costa; S D Murphy
Journal:  Toxicol Lett       Date:  1988-01       Impact factor: 4.372

8.  Neurology and neuropathology of Soman-induced brain injury: an overview.

Authors:  J M Petras
Journal:  J Exp Anal Behav       Date:  1994-03       Impact factor: 2.468

9.  Caramiphen and scopolamine prevent soman-induced brain damage and cognitive dysfunction.

Authors:  Lily Raveh; Ben Avi Weissman; Giora Cohen; David Alkalay; Ishai Rabinovitz; Hagar Sonego; Rachel Brandeis
Journal:  Neurotoxicology       Date:  2002-05       Impact factor: 4.294

10.  Atropine, an anticholinergic drug, impairs memory retrieval of a high consolidated avoidance response in mice.

Authors:  Mariano M Boccia; Mariano G Blake; Gabriela B Acosta; Carlos M Baratti
Journal:  Neurosci Lett       Date:  2003-07-17       Impact factor: 3.046

View more
  2 in total

1.  In vitro reactivation potency of acetylcholinesterase reactivators--K074 and K075--to reactivate tabun-inhibited human brain cholinesterases.

Authors:  Kamil Kuca; Jiri Cabal; Daniel Jun; Kamil Musilek
Journal:  Neurotox Res       Date:  2007-02       Impact factor: 3.911

Review 2.  The Experimental Oxime K027-A Promising Protector From Organophosphate Pesticide Poisoning. A Review Comparing K027, K048, Pralidoxime, and Obidoxime.

Authors:  Dietrich E Lorke; Georg A Petroianu
Journal:  Front Neurosci       Date:  2019-05-22       Impact factor: 4.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.